<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Genetics and Molecular Medicine</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C9B069BD-5D15-43B4-B0D6-6A64211DC850"><gtr:id>C9B069BD-5D15-43B4-B0D6-6A64211DC850</gtr:id><gtr:firstName>Ellen</gtr:firstName><gtr:surname>Solomon</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9600577"><gtr:id>D3D3F3DA-665C-4B66-BC18-C52FB558E1FD</gtr:id><gtr:title>Breast Cancer Genetics</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9600577</gtr:grantReference><gtr:abstractText>The human genome project has created enormous public interest and disquiet with regard to human genetics and its applications. As responsible researchers and geneticists it is important that we take every opportunity to allay ?Frankenstein? fears, and disseminate realistic information as to where medical genetics is leading. As a Division we are often approached by the press and broadcast media for views on high profile genetic stories, and attempt to deal with them in as even-handed and accurate a manner as possible. We encourage secondary school students to visit our Division, sometimes as part of work experience, to see what sorts of projects and problems we are working on; various members of the Division often speak at schools and to lay audiences of various types. One of our clinical consultants, Dr Fred Kavalier, is a well-known journalist who writes a weekly column for The Independent, and is often consulted on issues of public understanding.</gtr:abstractText><gtr:technicalSummary>This proposal deals with two different aspects of breast cancer genetics. The first aim is to further understand some of the structure/function relationships of wild type BRCA1, and the effects of the mutations which result in a dominantly transmitted, highly penetrant predisposition to early onset breast cancer. The second aim is to identify the genes that contribute to the more common, but complex, genetic predisposition to breast cancer. The N-terminus of BRCA1 contains a Ring Finger motif that exhibits E3 ubiquitin ligase activity, binds to BARD1 and a variety of other partners, is believed to be essential for at least some of DNA repair functions of the protein, and may also be involved in cell cycle control. We propose a series of studies based on our understanding of the structure of this motif, involving naturally occurring pathogenic mutations, missense mutations of uncertain pathogenicity, and amino acid substitutions that we shall introduce, to determine the contribution of different structural elements to these activities. We shall also introduce one of the pathogenic missense mutations into the mouse gene by homologous recombination, as a means of following some of these studies in an in vivo model. The second part of our proposal is a continuation of a genome wide search for additional breast cancer predisposing genes. As a result of our MRC funded collection of affected sib pairs, as part of the National DNA collections, we shall have available 500 sib pairs, in addition to the 177 pairs that have already been collected and genotyped. We shall continue to genotype with 400 microsatellite markers so as to determine whether our positive LOD scores are replicated or any new ones are detected. With nearly 700 sib pairs we will have 98% power to detect linkage at a lod score of 1.5 and 84% power for a LOD score of 3, at a lamda s of 1.5. If our results are replicated, we shall use SNP, or haplo-SNP markers, in association studies to localise and identify the genes.</gtr:technicalSummary><gtr:fund><gtr:end>2009-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1997-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1766367</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4834698B-3B1E-4085-BAF4-CD7E2EE68BEF</gtr:id><gtr:title>BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a504e0e8324fcdb6dc7914855d6deda0"><gtr:id>a504e0e8324fcdb6dc7914855d6deda0</gtr:id><gtr:otherNames>Drost R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>inDT6cHpiqv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81AA1CCA-D6FC-42ED-B226-A2A241390F43</gtr:id><gtr:title>Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer.</gtr:title><gtr:parentPublicationTitle>Genes, chromosomes &amp; cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dd08ca410475c3db2bf72727fccb476"><gtr:id>1dd08ca410475c3db2bf72727fccb476</gtr:id><gtr:otherNames>Izatt L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>1045-2257</gtr:issn><gtr:outcomeId>K2iPd4WvHM3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0408CD8F-BF07-4B4F-BBD6-503FEEB6C203</gtr:id><gtr:title>Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7d303ee8d5ce7df6ddefac3d71c4259"><gtr:id>b7d303ee8d5ce7df6ddefac3d71c4259</gtr:id><gtr:otherNames>Catteau A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>HGuW2LvUSre</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>868E2E80-A498-4218-9EA2-56F969469614</gtr:id><gtr:title>BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe2678acdbf4bea4a3b4151a9ef32224"><gtr:id>fe2678acdbf4bea4a3b4151a9ef32224</gtr:id><gtr:otherNames>Morris JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>MA8hFut74qD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8822AF8D-4C8C-4145-9345-90B98BD0B20C</gtr:id><gtr:title>Structural evolution of the BRCA1 genomic region in primates.</gtr:title><gtr:parentPublicationTitle>Genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0135a8ecf8670d81314c9c4f1bc84df9"><gtr:id>0135a8ecf8670d81314c9c4f1bc84df9</gtr:id><gtr:otherNames>Jin H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0888-7543</gtr:issn><gtr:outcomeId>fC5QgwvLBgH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8DD31D6-1C01-4124-8AFE-D79B31D46379</gtr:id><gtr:title>BRCA1 methylation: a significant role in tumour development?</gtr:title><gtr:parentPublicationTitle>Seminars in cancer biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7d303ee8d5ce7df6ddefac3d71c4259"><gtr:id>b7d303ee8d5ce7df6ddefac3d71c4259</gtr:id><gtr:otherNames>Catteau A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>1044-579X</gtr:issn><gtr:outcomeId>gZqiSkXRQAE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9418524-3F62-46D8-AEAA-78E49F9607C2</gtr:id><gtr:title>Germline BRCA1 promoter deletions in UK and Australian familial breast cancer patients: Identification of a novel deletion consistent with BRCA1:psiBRCA1 recombination.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6109f1e64385287a3e2c10b2d280ca53"><gtr:id>6109f1e64385287a3e2c10b2d280ca53</gtr:id><gtr:otherNames>Brown MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>ms4Wq1aZW8a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF112BDD-7A4A-4194-B9ED-E01A66854FBE</gtr:id><gtr:title>Expression of a truncated Brca1 protein delays lactational mammary development in transgenic mice.</gtr:title><gtr:parentPublicationTitle>Transgenic research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6109f1e64385287a3e2c10b2d280ca53"><gtr:id>6109f1e64385287a3e2c10b2d280ca53</gtr:id><gtr:otherNames>Brown MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0962-8819</gtr:issn><gtr:outcomeId>YyEjxnWMEEb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A831B97-5FA5-4718-8C2A-CEC5A5228BB2</gtr:id><gtr:title>The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe2678acdbf4bea4a3b4151a9ef32224"><gtr:id>fe2678acdbf4bea4a3b4151a9ef32224</gtr:id><gtr:otherNames>Morris JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>QmG4Lg5fe7s</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>884F1613-5A60-402C-AC5E-DC4543A11E8E</gtr:id><gtr:title>Identification of residues required for the interaction of BARD1 with BRCA1.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe2678acdbf4bea4a3b4151a9ef32224"><gtr:id>fe2678acdbf4bea4a3b4151a9ef32224</gtr:id><gtr:otherNames>Morris JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>PHnxgH31zPu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D66E88C-9539-4AD7-83EB-8253594EA51B</gtr:id><gtr:title>Rapid and efficient ATM mutation detection by fluorescent chemical cleavage of mismatch: identification of four novel mutations.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dd08ca410475c3db2bf72727fccb476"><gtr:id>1dd08ca410475c3db2bf72727fccb476</gtr:id><gtr:otherNames>Izatt L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>iZ7qF5kYq1t</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC574BF2-D057-425A-AC71-DB2B2CA8A75C</gtr:id><gtr:title>Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe2678acdbf4bea4a3b4151a9ef32224"><gtr:id>fe2678acdbf4bea4a3b4151a9ef32224</gtr:id><gtr:otherNames>Morris JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>emgGSFSFjB3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E742F0E2-51F6-479B-B8AE-B25ACEE4BE24</gtr:id><gtr:title>Gene replacement with the human BRCA1 locus: tissue specific expression and rescue of embryonic lethality in mice.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cbf71be76a94e99208f77edfd54d00a"><gtr:id>6cbf71be76a94e99208f77edfd54d00a</gtr:id><gtr:otherNames>Lane TF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2000-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>cGszrWEHCCx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CCD881B-882F-45F3-927B-24381962657E</gtr:id><gtr:title>Truncated TSG101 transcripts are present in peripheral blood from both familial breast cancer patients and controls.</gtr:title><gtr:parentPublicationTitle>European journal of cancer (Oxford, England : 1990)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/290c1daebbd1aceefc0f002e09baf2d3"><gtr:id>290c1daebbd1aceefc0f002e09baf2d3</gtr:id><gtr:otherNames>Xu CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1998-01-01</gtr:date><gtr:issn>0959-8049</gtr:issn><gtr:outcomeId>Z2Y1YgiHoeq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2B65FCB-2589-4CCF-9923-87CCEC314012</gtr:id><gtr:title>Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7d303ee8d5ce7df6ddefac3d71c4259"><gtr:id>b7d303ee8d5ce7df6ddefac3d71c4259</gtr:id><gtr:otherNames>Catteau A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>TkAVXXW46xo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EFB91C6-F7F3-4145-9D66-E2DDB49FA033</gtr:id><gtr:title>Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bfa234d188842a2bacdac22dd75213e"><gtr:id>3bfa234d188842a2bacdac22dd75213e</gtr:id><gtr:otherNames>Hodgson SV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1999-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>oXez4v7uHVV</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9600577</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>